Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02042625 · ClinicalTrials.gov registry record · NA
Optimal Positioning of Nasopharyngeal Temperature Probes: A Prospective Cohort Study
A NA study of Hypothermia, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT02042625: Completed NA study of Hypothermia, sponsored by The Cleveland Clinic.
NCT02042625 is a NA study of Hypothermia that has completed, run by The Cleveland Clinic. The registered enrollment target is 36 participants, below the 45-participant average among 9 other Hypothermia trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02042625, a NA study of Hypothermia, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Low body temperature (hypothermia) is often observed in anesthetized patients. Mild hypothermia increases complications such as surgical blood loss, postanesthesia recovery and the duration of hospitalization. To assess body temperature and minimize hypothermia-related complications, it is important to have accurate and reliable methods of measuring intraoperative core temperature. Common practice is to insert a nasopharyngeal (back of the throat from the nose) probe through one of the nostrils. However, there is no consensus or guideline regarding how deep the nasopharyngeal probe needs to be inserted. This study is being done to determine the insertion depth (or range of depths) that best approximates core temperature, which is temperature of the vital organs, e.g. heart, liver and lungs. Participation in the trial will occur on the day of surgery. The subject will be asked to breathe through one nostril and then the other before receiving anesthesia. The less congested nostril will be selected for study. If there is no difference, then the investigator will use the right nostril. Once under anesthesia, an esophageal temperature probe will be inserted to serve as a reference core temperature, which is used routinely in surgery. Then the nasopharyngeal probe will be inserted into the nostril. Both nasopharyngeal and esophageal temperatures will initially be recorded 45 minutes after anesthetic induction. The nasopharyngeal probe will then be withdrawn 2 cm and after a 3-minute equilibration period, nasopharyngeal and esophageal temperatures will again be recorded. The nasopharyngeal probe withdrawal sequence will be repeated, 2 cm at a time, until only 2 cm remains in the nostril. There will be a total of 10 sets of nasopharyngeal and esophageal temperatures obtained.
Conditions Studied
Interventions
- PROCEDURE Nasopharyngeal
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-10 |
| Phase | NA |
What the finished NCT02042625 record still lists
NCT02042625 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 45-participant average among 9 other Hypothermia trials with a reported enrollment target (20% lower).
The record links to 1 condition, with Hypothermia appearing as the primary indexed condition, and to 1 intervention - of which Nasopharyngeal is the first listed.
NCT02042625 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02042625 about?
NCT02042625 is a clinical study titled "Optimal Positioning of Nasopharyngeal Temperature Probes: A Prospective Cohort Study". Low body temperature (hypothermia) is often observed in anesthetized patients. Mild hypothermia increases complications such as surgical blood loss, postanesthesia recovery and the duration of hospitalization. To assess body temperature and minimize hypothermia-related complications, it is important...
What is the current status of trial NCT02042625?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2014-04. Estimated completion is 2015-10.
What conditions does trial NCT02042625 study?
This clinical trial studies the following conditions: Hypothermia.
What interventions are being tested in trial NCT02042625?
The interventions under investigation include: Nasopharyngeal (PROCEDURE).
Who is sponsoring clinical trial NCT02042625?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02042625 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypothermia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02042625's enrollment target sits among peer trials
36 6th of 9 higher than 4 of 9 other Hypothermia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypothermia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Blood Warming in Preterm Infants to Decrease Hypothermia
RECRUITING · NA
-
Neonatal Warming to Prevent Hypothermia
COMPLETED · NA
-
Thermal Compression Device for Maintenance of Perioperative Normothermia
COMPLETED · NA
-
Hypothermia to Treat Severe Brain Injury
COMPLETED · NA
-
Comparison of Bi-environmental Conditions During Occupational Related Activity
COMPLETED · NA
-
Safety and Performance Monitoring During Occupational Work II
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia